Frontiers in Immunology (Aug 2023)

Lifestyle interventions to prevent adverse pregnancy outcomes in women at high risk for gestational diabetes mellitus: a randomized controlled trial

  • Jiawei Xu,
  • Jiawei Xu,
  • Xuan Lin,
  • Ying Fang,
  • Jing Cui,
  • Zhi Li,
  • Fang Yu,
  • Libin Tian,
  • Hongyan Guo,
  • Xinyan Lu,
  • Xinyan Lu,
  • Jiahao Ding,
  • Jiahao Ding,
  • Lu Ke,
  • Lu Ke,
  • Jiahui Wu,
  • Jiahui Wu

DOI
https://doi.org/10.3389/fimmu.2023.1191184
Journal volume & issue
Vol. 14

Abstract

Read online

ObjectiveTo examine the effects of lifestyle interventions, including dietary guidance, health education and weight management, on pregnancy outcomes in women at high risk of gestational diabetes mellitus (GDM).MethodsOur study included 251 women at high risk of GDM and 128 randomized to lifestyle interventions (dietary guidance, health education, and weight management); One hundred and twenty-three people were randomly assigned to a control group (regular pregnancy check-ups). Counts between groups were compared using either chi-square test or Fisher’s exact test.ResultsCompared with the control group, the risk of GDM was reduced by 46.9% (16.4% vs 30.9%, P = 0.007) and the risk of pregnancy induced hypertension (PIH) was reduced by 74.2% (2.3% vs 8.9%, P = 0.034) in the intervention group. There were no significant differences in macrosomia, cesarean section, or preterm birth (P >0.05).ConclusionThe lifestyle intervention in this study helped pregnant women to better understand knowledge related to pregnancy, reduce stress and anxiety, and increase intake of adequate prenatal nutrition. This intervention prevented metabolic abnormalities that may occur due to inadequate nutrient intake during pregnancy. In addition, it helped women to control weight gain, maintain appropriate weight gain during pregnancy, and reduce the risk of excessive or insufficient weight gain, ultimately lowering the incidence of GDM and PIH. This highlights the importance of early screening and intervention for high-risk pregnant women.Clinical Trial Registrationhttps://www.chictr.org.cn, identifier ChiCTR2300073766.

Keywords